Biotech China 2014

View Profile

Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009 Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications Clin Cancer Res. 2009, in press.
2. 2009 Infusion reactions to monoclonal antibodies for solid tumors: Immunologic mechanisms and risk factors ONCOL. 2009, Vol 23, No 2 Suppl 1, p14-17.
3. 2009 Evolution of clinical trials in head and neck cancer Crit Rev Oncol Hematol. 2009, Vol 71, No 1, p29-42.
4. 2009 Hypothyroidism as a consequence of Intensity-Modulated Radiation Therapy with concurrent Taxane-based chemotherapy for locally-advanced head-and-neck cancer Int J Radiat Oncol Biol Phys. 2009, Jul 3 [Epub].
5. 2009 Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma Ann. Oncol. 2009, in press.
6. 2009 Validation of Lysyl Oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma – Radiation Therapy Oncology Group Trial 90-03 J Clin Oncol. 2009, Aug 10 [Epub].
7. 2009 Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: A tool to assess symptom burden in patients treated with chemoradiation Head & Neck. 2009, Jul 22 [Epub].
8. 2009 A feed-forward loop involving Protein Kinase C Alpha and microRNAs regulates tumor cell cycle Cancer Res. 2009, Vol 69, No 1, p65-74.
9. 2009 Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer J Clin Invest. 2009, Vol 119, No 6, p1571-82.
10. 2009 Human papillomavirus in early laryngeal carcinoma Laryngoscope. 2009, Jun 1 [Epub].
11. 2008 Transforming Growth Factor-beta engages TACE and ErbB3 to activate PI3K/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab Mol Cell Biol. 2008, Vol 28, No 18, p5605-5620.
12. 2008 Cetuximab-induced anaphylaxis and IgE antibodies against galactose-alpha-1,3-galactose N Engl J Med. 2008, Vol 358, No 11, p1109-1117.
13. 2008 Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma Br J Cancer. 2008, Vol 98, No 3, p619-626.
14. 2008 Cetuximab-induced hypersensitivity: case reports and discussion of management Oncol Nurse. 2008, Vol 1, No 2, p17-19.
15. 2008 Managing premedications and risk of reactions to infusional monoclonal antibody therapy Oncologist. 2008, Vol 13, No 6, p725-732.
16. 2008 Update in molecular diagnostic tests in head and neck cancer Semin Oncol. 2008, Vol 35, No 3, p198-210.
17. 2008 Gene expression profiles identify epithelial-to-mesenchymal transition and activation of Nuclear Factor-ĸB signaling as characteristics of a high-risk head and neck squamous cell carcinoma Cancer Res. 2006, Vol 66, No 16, p8210-8218.
18. 2008 Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck Cancer. 2008, Vol 113, No 1, p186-192.
19. 2007 Genomics and proteomics: Emerging technologies in clinical cancer research Crit Rev Oncol Hematol. 2007, Vol 61, No 1, p1-25
20. 2007 Strategic plans to promote head and neck cancer translational research within Radiation Therapy Oncology Group: A report from the Translational Research Program Int J Radiat Oncol Biol Phys. 2007, Vol 69, No 2 Suppl, pS67-S78.
21. 2007 Single agent Irinotecan for the treatment of metastatic or recurrent squamous carcinoma of the head and neck (SCCHN) Clin Med Oncol. 2007, Vol 1, p67-71
22. 2007 Gene expression profiles as markers of aggressive disease – EGFR as a factor Int J Radiat Oncol Biol Phys. 2007, Vol 69, No 2 Suppl, pS102-S105.
23. 2006 Chapter 9: Esthesioneuroblastoma Barbara A. Murphy, Joseph M. Aulino, Christine H. Chung, Kim Ely, Robert Sinard and Anthony Cmelak.
24. 2006 Chapter 9: Esthesioneuroblastoma John Wiley & Sons, Ltd. 2006, p133-142.
25. 2006 Epidermal Growth Factor Receptor: An overview of trials in head and neck and lung cancer [Commentary ONCOL.2006, Vol 20, No 2, p162, 166.
26. 2006 Clinical applications of genomics in head and neck cancer Head Neck. 2006, Vol 28, No 4, p360-368.
27. 2006 Increased EGFR gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol. 2006, Vol 24, No 25, p4170-4176.
28. 2006 Gene expression differences associated with HPV status in head and neck squamous cell carcinoma Clin Cancer Res. 2006, Vol 12, No 3, p701-709.
29. 2004 Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression Cancer Cell. 2004, Vol 5, p489-500.
30. 2003 49 year-old male with locally advanced squamous cell carcinoma of the head and neck: The case for sequential chemoradiotherapy programs [Commentary] Clin Adv in Hematol & Oncol. 2003, Vol 1, No 1, p61-62.
31. 2002 Molecular portraits and the family trees of cancer Nat Genet. 2002, Suppl. Vol 32, p533-540.
32. 2000 In-frame deletions of BRCA1 may define critical functional domains Hum Genet. 2000, Vol 107, p385-390.
33. 1998 Detection of K-ras mutations in duodenal fluid-derived DNA: Can it be used to diagnose cancer of the pancreas Cancer. 1998, Vol 82, No 1, p96-103.
34. 1996 Clinical significance of K-ras oncogene activation in ampullary neoplasms J Clin Pathol. 1996, Vol 49, No 6, p460-464.

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.